Fulgent Genetics Inc. (FLGT)
NASDAQ · Healthcare
Fulgent Genetics Inc. Revenue 2014–2025
Fulgent Genetics Inc. annual/quarterly revenue history and growth rate from 2014 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Fulgent Genetics Inc. revenue for the quarter ending March 31, 2026 was 71.1 M, a 3.16% decrease year-over-year.
- Fulgent Genetics Inc. revenue for the twelve months ending March 31, 2026 was 310.5 M, a 6.35% increase year-over-year.
- Fulgent Genetics Inc. annual revenue for 2025 was 322.7 M, a 13.83% increase from 2024.
- Fulgent Genetics Inc. annual revenue for 2024 was 283.5 M, a 1.99% decrease from 2023.
- Fulgent Genetics Inc. annual revenue for 2023 was 289.2 M, a 53.27% decrease from 2022.
- Fulgent Genetics Inc. annual revenue for 2022 was 619.0 M.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Fulgent Genetics Inc. Earnings — FAQ
Fulgent Genetics Inc. (FLGT) earnings over the last 12 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see FLGT's earnings history?
The chart and table above show Fulgent Genetics Inc.'s earnings by year and by quarter, including the growth rate.